Skip to content

Castle Biosciences CSTL Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$14.52M+43.8%-$2.33M-124%-$501K-122%$4.52M-49.3%-$25.85M-920%
$3.93M-86.8%$3.78M-34.5%$3.82M+7.8%$3.41M+2.0%$29.76M+791%
$9.78M-12.6%$11.41M-0.3%$12.1M-7.1%$11.21M-15.0%$11.18M-11.8%
-$22.13M-267%$26.93M+10.5%$22.63M-3.0%$20.82M-13.2%-$6.04M+11.7%
$12.46M+163%$7.18M-5.1%$14.83M+133%$9.26M+77.1%$4.74M-48.2%
-$25.8M-15.0%-$18.39M-24.3%-$28.38M-32.5%-$22.43M-13.9%
-$5.03M-224%-$4.59M-$919K-210%$0-100%-$1.55M-115%
-$52.97M-76.4%-$7.46M-$30.02M-88.9%
-$34.58M-221%$19.75M+17.6%$7.8M-54.0%$11.56M-38.4%-$10.78M+32.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Castle Biosciences generate?
Castle Biosciences (CSTL) generated $48.3M in operating cash flow over the trailing twelve months.
What is Castle Biosciences's free cash flow?
After $43.7M of capital expenditures, Castle Biosciences's free cash flow was $4.5M over the trailing twelve months, down 89.2% year over year.
Where does Castle Biosciences's cash flow data come from?
Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.